Flubromazolam is not identified to own any therapeutic use, is just not within the WHO Product List of Critical Medicines and has never been marketed as a medicinal product or service.A single pharmacokinetics examine showed that a dose of 0.five mg flubromazolam induced strong sedative effects that lasted a lot more than 10 h and caused partial am